The parent company to American Medical Systems has agreed to an $830 million transvaginal mesh lawsuit settlement to resolve claims from women who allege injuries caused by its pelvic implants, according to Reuters.com.

Endo International Plc announced on April 30th some details of an agreement it said would cover “a substantial majority of the mesh litigation” involving the company’s products, to which they do not admit fault or liability. Last year, Endo paid $54.5 million to resolve other lawsuits and has previously set aside a $520 million reserve to cover legal expenses stemming from claims alleging mesh erosion, organ damage, vaginal scarring, infection and other side effects. An annual filing with the U.S. Securities and Exchange Commission revealed on February 20th that the companies were together named defendant in approximately 22,000 transvaginal mesh lawsuits over products from American Medical Systems products.

According to Reuters, the settlement will not go into effect until medical records for plaintiffs are confirmed, and several other conditions are met. Endo said it will pay a pretax charge of $625 million to compensate for costs of the settlement, which may be implemented in the next year.

The report indicates that plaintiffs who may be affected by the agreement are happy with its results, which the lawyer for the party said reflects an “adversarial but respectful and professional negotiation on the part of all the parties.”

More than 16,500 Mesh Lawsuits Filed in Federal AMS Litigation

Over the past few years, transvaginal mesh lawsuits against American Medical Systems have continued to move forward. A federal Case List updated on April 15th indicates that 16,515 cases had been filed in a multidistrict litigation currently underway in the U.S. District Court, Southern District of West Virginia on behalf of women who accuse the company of failing to adequately warn about side effects that may be associated with its products. As a result, thousands of patients were put in danger of sustaining serious and debilitating injuries caused by devices designed to treat pelvic organ prolapse (POP).

The same week Endo announced its transvaginal mesh lawsuit agreement, the U.S. Food and Drug Administration (FDA) issued a proposal that would classify similar devices as “high risk,” according to Reuters. If the new regulations are implemented, all pelvic mesh manufacturers will be required to submit their devices for pre-market safety testing and approval in order to continue selling them.

Filing a Transvaginal Mesh Lawsuit

If you received an implant from American Medical Systems, you may be eligible to file a vaginal mesh lawsuit. Call our Firm today at (877) 779-1414 to learn more about the mounting litigation against this company, and several others.

Published May 1, 2014 by